Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shopko Optical is a U.S. optical retail and eye care company that provides comprehensive eye exams, prescription eyewear, contact lenses, and related optical services through a network of more than 140 stores across the Upper Midwest and western United States. The business traces its optical operations to 1978 and was separated from the former Shopko retail chain in 2019, when Monarch Alternative Capital acquired the optical assets and established the business as a standalone company. Shopko Optical operates as a consumer-facing healthcare services and medical retail business rather than a drug-development biotech or pharmaceutical company. In 2024, Fielmann Group, through Fielmann USA, agreed to acquire Shopko Optical, and company materials describe it as part of Fielmann USA. The company continues to expand through de novo locations and tuck-in acquisitions of regional optical practices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shopko Optical.